
OptiLight by Lumenis is a safe, gentle, non-invasive treatment for dry eye disease and the first FDA-approved intense pulsed light (IPL) therapy for this condition. It delivers controlled pulses of light to help reduce dry eye symptoms. Using patented Optimal Pulse Technology (OPT), it delivers precise, consistent light energy to safely and comfortably treat the underlying cause of dry eye. The result is an effective, non-invasive treatment that helps improve gland function and reduce dry eye symptoms. Each session typically takes about 15-20 minutes, and patients with dry eye disease related to meibomian gland disease, blepharitis, Demodex and ocular rosacea often see improvement after a series of four treatments.
This treatment can improve dry eye by increasing tear stability, reducing bacteria and Demodex mites around the eyes, lowering inflammation, and improving meibomian gland function.

Dry eye disease can cause a variety of symptoms, including:
Dryness or a gritty, sandy sensation
Burning or stinging eyes
Redness and irritation
Excessive tearing or watery eyes
Fluctuating or blurred vision
Eye fatigue, especially during reading or screen use
Eyelid itching or irritaion
Sensitivity to light
Stringy mucus in or around the eyes
Difficulty wearing contact lenses
A feeling that something is in your eye (foreign body sensation)
If you are experiencing any of these symptoms, schedule an eye exam to determine the cause and discuss appropriate treatment options to help manage your dry eye.